Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation
Harshad P. Patil, Danielle Freches, Linda Karmani, et al.
Journal of Controlled Release (2017) Vol. 272, pp. 62-71
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Research progress on the PEGylation of therapeutic proteins and peptides (TPPs)
Chunxiao Li, Ting Li, Xinya Tian, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 18
Pulmonary Delivery of Biological Drugs
Wanling Liang, Harry W. Pan, Driton Vllasaliu, et al.
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1025-1025
Open Access | Times Cited: 130
Temperature- and rigidity-mediated rapid transport of lipid nanovesicles in hydrogels
Miaorong Yu, Wenyi Song, Falin Tian, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 12, pp. 5362-5369
Open Access | Times Cited: 111
Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery
Hannah C. Zierden, Aditya Josyula, Rachel Shapiro, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 5, pp. 436-450
Open Access | Times Cited: 68
Engineered Polymer–siRNA Polyplexes Provide Effective Treatment of Lung Inflammation
Taewon Jeon, David C. Luther, Ritabrita Goswami, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 4315-4326
Open Access | Times Cited: 25
Rational particle design to overcome pulmonary barriers for obstructive lung diseases therapy
Yuan He, Yingmin Liang, Run Han, et al.
Journal of Controlled Release (2019) Vol. 314, pp. 48-61
Closed Access | Times Cited: 66
Challenges and Strategies to Enhance the Systemic Absorption of Inhaled Peptides and Proteins
Qin Lu, Zhixiang Cui, Yu Wu, et al.
Pharmaceutical Research (2022) Vol. 40, Iss. 5, pp. 1037-1055
Open Access | Times Cited: 28
Inhaled drug delivery for the targeted treatment of asthma
Allison Boboltz, Sahana Kumar, Gregg A. Duncan
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114858-114858
Closed Access | Times Cited: 20
Self‐Propelled Proteomotors with Active Cell‐Free mtDNA Clearance for Enhanced Therapy of Sepsis‐Associated Acute Lung Injury
Wei‐Chang Huang, Lihong Wen, Hao Tian, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 17
Protein and peptide delivery to lungs by using advanced targeted drug delivery
Dinesh Kumar Chellappan, Parteek Prasher, Vilashini Saravanan, et al.
Chemico-Biological Interactions (2021) Vol. 351, pp. 109706-109706
Closed Access | Times Cited: 36
PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19
B. Rabindran Jermy, Vijaya Ravinayagam, Dana Almohazey, et al.
Applied Clay Science (2021) Vol. 216, pp. 106333-106333
Open Access | Times Cited: 34
Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy
Yu Tang, Lanfang Zhang, Rui Sun, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 4, pp. 100833-100833
Open Access | Times Cited: 13
Models to evaluate the barrier properties of mucus during drug diffusion
Liu Liu, Chunling Tian, Baoqi Dong, et al.
International Journal of Pharmaceutics (2021) Vol. 599, pp. 120415-120415
Closed Access | Times Cited: 28
Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice
Jiaqi Li, Zherui Zhang, Hongqing Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 27
PEGylated Nanocarriers for Protein and Peptide Delivery
Tejas Girish Agnihotri, Vasu Peddinti, Shyam Sudhakar Gomte, et al.
(2025), pp. 295-316
Closed Access
Impact of administration route and PEGylation on alpha-1 antitrypsin augmentation therapy
Xiao Liu, Bernard Učakar, Kévin Vanvarenberg, et al.
Journal of Controlled Release (2025), pp. 113643-113643
Closed Access
Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung
Alejandro Nieto‐Orellana, Huiqi Li, Rémi Rosière, et al.
Journal of Controlled Release (2019) Vol. 316, pp. 250-262
Open Access | Times Cited: 27
Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
Yara Al Ojaimi, Timothée Blin, Juliette Lamamy, et al.
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108022-108022
Open Access | Times Cited: 22
Clustered nanobody–drug conjugates for targeted cancer therapy
Tiantian Wu, Manman Liu, Hai Huang, et al.
Chemical Communications (2020) Vol. 56, Iss. 65, pp. 9344-9347
Closed Access | Times Cited: 22
Synthetic mucus barrier arrays as a nanoparticle formulation screening platform
Harry Zou, Allison Boboltz, Yahya Cheema, et al.
RSC Pharmaceutics (2024) Vol. 1, Iss. 2, pp. 218-226
Open Access | Times Cited: 2
Pegylation, a Successful Strategy to Address the Storage and Instability Problems of Blood Products: Review 2011-2021
Tahereh Zadeh Mehrizi, M. Mirzaei, Mehdi Shafiee Ardestani
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 3, pp. 247-267
Closed Access | Times Cited: 6
In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8/CxCL-1 siRNA Delivery to the Lungs
Alan Hibbitts, Joanne M. Ramsey, James W. Barlow, et al.
Nanomaterials (2020) Vol. 10, Iss. 7, pp. 1248-1248
Open Access | Times Cited: 15
Biodistribution and elimination pathways of PEGylated recombinant human deoxyribonuclease I after pulmonary delivery in mice
Sohaib Mahri, Aurélie Rondon, Tobias Wilms, et al.
Journal of Controlled Release (2020) Vol. 329, pp. 1054-1065
Open Access | Times Cited: 15
Advances in Lipid-Based Pulmonary Nanomedicine for The Management of Inflammatory Lung Disorders
Manish Kumar, Abhishek Jha, Kanchan Bharti, et al.
Nanomedicine (2022) Vol. 17, Iss. 12, pp. 913-934
Closed Access | Times Cited: 9
Barriers for orally inhaled therapeutic antibodies
Thomas Sécher, Nathalie Heuzé-Vourc’h
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1071-1084
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top